924 results on '"Evans DB"'
Search Results
2. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes
3. Abstracts from the sixth meeting of the international association of pancreatology, November 2–4, 1994, Chicago, IL
4. Assessment of the Thyroid Function of Patients Undergoing Regular Haemodialysis
5. Medullary thyroid cancer: management guidelines of the American Thyroid Association
6. Hypertensive Exercise Responses in Ciclosporin-Treated Normotensive Renal Transplant Recipients
7. Cost-effeciveness analysis: can we reduce variability in costing methods?
8. Formal response to 'Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues'
9. Stochastic League tables: communicating cost-effectiveness results to decision makers
10. Abstract P1-12-06: Outcome of Frail Elderly Patients Treated with Letrozole Alone
11. Abstract P1-12-05: Factors Affecting Local Recurrence after Breast Conserving Surgery Following Neoadjuvant Endocrine Therapy with Letrozole
12. Phosphatidyl-inositol-3-kinase Alpha catalytic subunit kinase domain mutations impart a favorable prognosis on estrogen receptor positive breast cancer through a mechanism that is independent of responsiveness to endocrine treatment.
13. Preclinical modeling of endocrine response: a combination therapy approach with the ERβ agonist, diarryl propionitrile and letrozole restores sensitivity to letrozole-resistant breast cancer cells.
14. Effects of letrozole and anastrozole on low ER expressing invasive breast carcinomas: results from a randomised trial.
15. Proteomics analysis of tissue samples obtained before and during letrozole treatment in postmenopausal patients with locally advanced breast cancer.
16. A synergistic suppression of aromatase by letrozole and the DAC inhibitor panobinostat (LBH589), an inhibitory modulator of aromatase gene expression.
17. Antitumor activity of chemoendocrine therapy in premenopausal (capecitabine [CAP] + tamoxifen [TAM]) and postmenopausal (CAP + letrozole [LET]) human breast cancer [BC] xenograft models.
18. Computational inference of gene expression signatures differentiating between breast cancers responsive or resistant to letrozole.
19. Molecular genetics of pancreatic cancer
20. Presumed malignant biliary obstruction despite a normal CT: Data to support pancreatico-duodentectomy (PD)
21. Major vascular resection as part of pancreatico-duodenctomy for cancer: Clinical, radiologic and pathologic analysis
22. Association of gastric adenocarcinoma with the HLA class II gene DQB10301
23. CISPLATIN, 5-FLUOROURACIL, AND LEUCOVORIN IN THE THERAPY OF ADENOCARCINOMAS OF THE PANCREAS
24. Pancreatic malignancy involving the superior mesenteric-portal vein confluence is not a contraindication to pancreaticoduodenectomy
25. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head: Survival and pattern of failure analysis
26. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.
27. Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.
28. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
29. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.
30. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.
31. Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer.
32. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.
33. Cost effectiveness analysis of strategies to combat malaria in developing countries [corrected] [published erratum appears in BMJ 2006 Jul 8;333(7558):86].
34. Household catastrophic health expenditure: a multicountry analysis.
35. Comparative efficiency of national health systems: cross national econometric analysis.
36. Should governments subsidize the use of insecticide-impregnated mosquito nets in Africa? Implications of a cost-effectiveness analysis.
37. Reversed rhythm of kidney transplants
38. URINARY RHYTHM AFTER RENAL TRANSPLANTATION
39. The challenge of private insurance for public good.
40. Multimodality management of localized pancreatic cancer.
41. Development assistance for health: should policy-makers worry about its macroeconomic impact?
42. Exploring the features of universal coverage.
43. Nonlocalizing imaging studies for hyperparathyroidism: where to explore first?
44. The health worker shortage in Africa: are enough physicians and nurses being trained?
45. Universal coverage of health services: tailoring its implementation.
46. Does the Integrated Management of Childhood Illness cost more than routine care? Results from the United Republic of Tanzania.
47. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.
48. P16. Generation of osteoblast-like cells from long-term human marrow cultures in vitro
49. 13. Regulation of osteocalcin production in human osteoblast-like cells
50. P28. Regulation of human osteoblast-like cell activity by granulocyte-macrophage colony-stimulating factor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.